Supplementary Material from A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling &lt;i&gt;in vitro&lt;/i&gt; and inhibits insulin-like growth factor-I receptor–dependent tumor growth &lt;i&gt;in vivo&lt;/i&gt;